| 发明名称 |
Treatment of complement-associated disorders |
| 摘要 |
The present invention concerns a recently discovered macrophage specific receptor, STIgMA, and its use in the treatment of complement-associated disorders.
|
| 申请公布号 |
US2005214308(A1) |
申请公布日期 |
2005.09.29 |
| 申请号 |
US20040964263 |
申请日期 |
2004.10.12 |
| 申请人 |
ASHKENAZI AVI;HELMY KARIM Y;FONG SHERMAN;GODDARD AUDREY;GURNEY AUSTIN L;KATSCHKE KENNETH J JR;NAPIER MARY A;TUMAS DANIEL;LOOKEREN MENNO V;WOOD WILLIAM I |
发明人 |
ASHKENAZI AVI;HELMY KARIM Y.;FONG SHERMAN;GODDARD AUDREY;GURNEY AUSTIN L.;KATSCHKE KENNETH J.JR.;NAPIER MARY A.;TUMAS DANIEL;LOOKEREN MENNO V.;WOOD WILLIAM I. |
| 分类号 |
A61K39/395;C07K14/705;C07K16/28;(IPC1-7):A61K39/395 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
